Atlas Trials

A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment

Clinical trial NCT01512849 · COMPLETED

Trial details

NCT number
NCT01512849
Sponsor
Tanabe Pharma Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2012-01-01
Primary completion
2012-09-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.